The weekly litigation news digest is live. Subscribe now

IP Verse

Modified Nucleotides For Polynucleotide Sequencing - EP3002289

The patent EP3002289 was granted to Illumina Cambridge on Feb 28, 2018. The application was filed on Aug 22, 2003 under application number EP15184520A. The patent is currently recorded with a legal status of "Revoked".

EP3002289

ILLUMINA CAMBRIDGE
Application Number
EP15184520A
Filing Date
Aug 22, 2003
Status
Revoked
Jun 19, 2023
Publication Date
Feb 28, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
MGI TECH HONG KONGApr 29, 2020BUDDE SCHOUINTERVENTION ADMISSIBLE
HOFFMANN EITLENov 28, 2018HOFFMANN EITLEADMISSIBLE

Patent Citations (17) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS5302509
DESCRIPTIONWO0006770
DESCRIPTIONWO0229003
DESCRIPTIONWO03048387
OPPOSITIONEP1046648
OPPOSITIONEP2325304
OPPOSITIONGB230037
OPPOSITIONGB303924
OPPOSITIONUS2002019363
OPPOSITIONUS2003104437
OPPOSITIONUS5547839
OPPOSITIONWO0053805
OPPOSITIONWO0192284
OPPOSITIONWO0229003
OPPOSITIONWO9106678
OPPOSITIONWO9627025
SEARCHWO0229003

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents